![Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study | BMC Geriatrics | Full Text Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study | BMC Geriatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12877-018-0984-z/MediaObjects/12877_2018_984_Fig1_HTML.png)
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study | BMC Geriatrics | Full Text
![Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology](https://www.frontiersin.org/files/Articles/535396/fimmu-11-01301-HTML/image_m/fimmu-11-01301-g004.jpg)
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology
![31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two | Journal for ImmunoTherapy of Cancer 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/4/Suppl_1/73/F68.medium.gif)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two | Journal for ImmunoTherapy of Cancer
![Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology](https://www.frontiersin.org/files/MyHome%20Article%20Library/683131/683131_Thumb_400.jpg)
Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology
![Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d44cad7d-83f5-4229-b871-b7d90b15b89c/joim.2016.279.issue-6.cover.jpg)
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library
![Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study - Kinnunen - 2018 - Alzheimer's & Dementia - Wiley Online Library Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study - Kinnunen - 2018 - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/2d4d2cfb-10a2-4055-b6db-d78a2f4ebd1a/alzjjalz2017062268-fig-0001-m.jpg)
Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study - Kinnunen - 2018 - Alzheimer's & Dementia - Wiley Online Library
![The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research & Therapy | Full Text The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-018-0396-5/MediaObjects/13195_2018_396_Fig1_HTML.png)
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research & Therapy | Full Text
![Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a3c5671-f165-4727-9901-d9fd0079dd7d/gr1_lrg.jpg)
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology
![Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0a09202f-fe96-4bb5-9dfd-a6bedd554697/joim12482-fig-0001-m.jpg)
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library
![Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology](https://www.frontiersin.org/files/Articles/535396/fimmu-11-01301-HTML/image_m/fimmu-11-01301-g003.jpg)
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology
![Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/dc026107-3608-4289-8144-4939e7fb312e/gr2_lrg.jpg)
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology
![Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease - ScienceDirect Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0197458019301010-gr1.jpg)
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease - ScienceDirect
![Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology](https://www.frontiersin.org/files/Articles/683131/fneur-12-683131-HTML-r2/image_m/fneur-12-683131-t001.jpg)